Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time

PLoS One. 2016 Sep 9;11(9):e0161710. doi: 10.1371/journal.pone.0161710. eCollection 2016.

Abstract

Background: Although subtypes of chronic obstructive pulmonary disease are recognized, it is unknown what happens to these subtypes over time. Our objectives were to assess the stability of cluster-based subtypes in patients with stable disease and explore changes in clusters over 1 year.

Methods: Multiple correspondence and cluster analysis were used to evaluate data collected from 543 stable patients included consecutively from 5 respiratory outpatient clinics.

Results: Four subtypes were identified. Three of them, A, B, and C, had marked respiratory profiles with a continuum in severity of several variables, while the fourth, subtype D, had a more systemic profile with intermediate respiratory disease severity. Subtype A was associated with less dyspnea, better health-related quality of life and lower Charlson comorbidity scores, and subtype C with the most severe dyspnea, and poorer pulmonary function and quality of life, while subtype B was between subtypes A and C. Subtype D had higher rates of hospitalization the previous year, and comorbidities. After 1 year, all clusters remained stable. Generally, patients continued in the same subtype but 28% migrated to another cluster. Together with movement across clusters, patients showed changes in certain characteristics (especially exercise capacity, some variables of pulmonary function and physical activity) and changes in outcomes (quality of life, hospitalization and mortality) depending on the new cluster they belonged to.

Conclusions: Chronic obstructive pulmonary disease clusters remained stable over 1 year. Most patients stayed in their initial subtype cluster, but some moved to another subtype and accordingly had different outcomes.

MeSH terms

  • Aged
  • Cluster Analysis
  • Comorbidity
  • Dyspnea / physiopathology
  • Exercise Tolerance / physiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Quality of Life

Grants and funding

This work was supported by Fondo de Investigación Sanitaria [grant number PI020510], and by Departamento de Sanidad del Gobierno Vasco [grant number 200111002] Ministerio de Economía y Competitividad del Gobierno de España (MTM2013-40941-P), Departamento de Educación, Política Lingüística y Cultura del Gobierno Vasco (IT620-13).